Phage therapy program
Balgrist Phage Therapy and Research / REPhRAME
| Status | Intake unconfirmed |
|---|---|
| Type | Center |
| Location | Zurich; Switzerland |
| Entry review | 2026-10-03 |
Access and enquiries
| How to enquire | Balgrist announces a five-year EU-funded program beginning June 2026; no general public phage intake route or recruiting trial established in this pass. |
|---|---|
| Areas of work | Recurrent urinary tract infections; REPhRAME plans engineered E. coli phages followed by microbiota transfer. |
| International access | Multinational research consortium, not an established cross-border patient referral network. |
What to confirm
- Funding and trial plans do not establish that recruitment has begun.
- Other consortium partners are not automatically treating centers.
Sources and updates
Entry reviewed . This is the date of our source review, not a confirmation of availability today.
AI helped us research this directory. Details may be wrong or out of date. Confirm availability with the clinic or study team. Suggest a correction.
| Program ID | eu-balgrist-rephrame |
|---|